Do you want to read an article? Please log in or register.
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry
Macular Diseases
Related content
Macular Diseases
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes
Ophthalmol Retina.
Ciulla TA, Hussain RM, Pollack JS, Williams DF
doi: 10.1016/j.oret.2019.05.017.
Macular Diseases
SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States
Ophthalmol Retina.
Khanani AM, Skelly A, Bezlyak V, Griner R, Torres LR, Sagkriotis A
doi: 10.1016/j.oret.2019.09.009.
COMMENTED
Macular Diseases
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
★ 2
Recommended and commented by
Prof. Dr Stephan Michels, Faculty Member
BMC Ophthalmol.
Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, Sakamoto T, Wong TY, Pantiri K, Carrasco J
doi: 10.1186/s12886-020-01554-2.
Blindness and Vision ImpairmentMacular Diseases
Early predictive factors of visual loss at 1-year in neovascular age-related macular degeneration under anti-VEGF in the GEFAL study
Ophthalmol Retina
Kodjikian L, Rezkallah A, Decullier E, Aulagner G, Huot L, Mathis T, GEFAL Study Group.
doi: 10.1016/j.oret.2021.04.015
Macular Diseases
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Adv Ther.
Carrasco J, Pietsch GA, Nicolas MP, Koerber C, Bennison C, Yoon J
doi: 10.1007/s12325-019-01147-6.
Macular DiseasesFurther Publications
Real-world outcomes of anti-VEGF therapy in treatment-naïve neovascular age-related macular degeneration diagnosed on OCT angiography: the REVEAL study
Acta Ophthalmol
Lupidi M, Schiavon S, Cerquaglia A, Fruttini D, Gujar R, Muzi A, Fiore T, Reibaldi M, Chhablani J, Cagini C
doi: 10.1111/aos.15005
Macular Diseases
Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol.
Stem MS, Moinuddin O, Kline N, Thanos A, Rao P, Williams GA, Hassan TS
Macular Diseases
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial
JAMA Ophthalmol.
Ramakrishnan MS, Yu Y, VanderBeek BL
doi: 10.1001/jamaophthalmol.2019.4577.
Glaucoma and Ocular PressureMacular DiseasesOcular Oncology
Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Invest Ophthalmol Vis Sci.
Wen JC, Reina-Torres E, Sherwood JM, Challa P, Liu KC, Li G, Chang JY, Cousins SW, Schuman SG, Mettu PS, Stamer WD, Overby DR, Allingham RR
doi: 10.1167/iovs.16-20786.